A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes-Reference-Cited by-同舟云学术

A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes

Published:2015 Issue:12 Volume:62 Page:1049-1057
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Son Jang-Won¹,Lee In-Kyu²,Woo Jeong-taek³,Baik Sei Hyun⁴,Jang Hak Chul⁵,Lee Kwan Woo⁶,Cha Bong Soo⁷,Sung Yeon-Ah⁸,Park Tae Sun⁹,Yoo Soon-Jib¹,Yoon Kun-Ho¹⁰

Affiliation:

1. Department of Internal Medicine, College of Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea, Bucheon, Korea

2. Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea

3. Department of Endocrinology and Metabolism, Research Institute of Endocrinology, School of Medicine, Kyung Hee University, Seoul, Korea

4. Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea

5. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

6. Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea

7. Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

8. Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea

9. Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea

10. Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/62/12/62_EJ15-0325/_pdf

Reference27 articles.

1. 1. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.

2. 2. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.

3. 3. Monnier L, Lapinski H, Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26: 881-885.

4. 4. El-Kebbi IM, Ziemer DC, Cook CB, Gallina DL, Barnes CS, et al. (2004) Utility of casual postprandial glucose levels in type 2 diabetes management. Diabetes Care 27: 335-339.

5. 5. Wang JS, Tu ST, Lee IT, Lin SD, Lin SY, et al. (2011) Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring. Diabetes Metab Res Rev 27: 79-84.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes;Current Oncology Reports;2022-11-29

2. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose;Diabetes Technology & Therapeutics;2021-03-01

3. Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review;Diabetes Therapy;2019-04-24

4. Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis;Oncotarget;2017-04-28